STRATA Skin Sciences Inc
SSKN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$930
Close$
$-2.26
2256300% downside
Current Fair Value
2256300% downsideOvervalued by 2256300% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $930.00 |
|---|---|
| Enterprise Value | $11.29 Million |
| Earnings per Share | $-1.35 |
| Beta | -0.05 |
| Outstanding Shares | 5,888,199 |
Return
| Return on Equity | -215.30% |
|---|---|
| Return on Assets | -20.51% |
| Return on Invested Capital | -107.67% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.37 |
| Enterprise Value to EBIT | -2.77 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.7 |
| Debt to Equity | 6.6 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$-0.43
Consensus analyst estimateRevenue Estimate
$5.53 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$-0.38
Consensus analyst estimateRevenue Estimate
$5.41 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About STRATA Skin Sciences Inc
CEO: Dolev Rafaeli
STRATA Skin Sciences is a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTR...